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Background: Epidermal growth factor receptor (EGFR) is a member of the receptor tyrosine kinase (RTK) family.
Epidermal growth factor induces its dimerization and stimulates phosphorylation of intracellular tyrosine residues.
Phosphorylation of EGFR is studied for cancer therapy because EGFR regulates many cellular processes including
cell proliferation, differentiation, and survival. Hence, down-regulation of EGFR kinase activity results in inhibition of
signaling cascades amenable for proliferation and progression of cell cycle.
Methods: In the study, we purified 3,4-dihydroxyphenyl acetic acid and (+)-epoxydon from Aspergillus sp. isolated
from marine brown alga Ishige okamurae and Phoma herbarum isolated from marine red alga Hypnea saidana
respectively and determined its anti-tumor activities against HeLa human cervical cancer cells.
Results: Two compounds suppressed EGFR activity in vitro with IC50 values for 3,4-dihydroxyphenyl acetic acid and
(+)-epoxydon were 2.8 and 0.6 μg/mL respectively and reduced the viable numbers of HeLa cells. Immunoblotting
analysis exhibited that the compounds induced inhibition of cell growth by causing downregulation of the
mitogenic signaling cascade, inactivation of p90RSK, and release of cytochrome c from mitochondria.
Conclusions: Results suggest that decreased expression of active EGFR and EGFR-related downstream molecules by
treatment with the compounds may results in the inhibition of cell growth and inducement of apoptosis.
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Epidermal growth factor (EGF) receptor (EGFR) is a type
1 receptor tyrosine kinase or member of the ErbB (HER)
receptor family [1]. The EGFR receptor is divided into
an extracellular ligand-binding domain, which is an an-
chor domain that spans the membrane, and an intracel-
lular component that activates tyrosine kinase and
induces further downstream signaling [2]. After ligand* Correspondence: cykim@gnu.ac.kr; gundokim@pknu.ac.kr
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reproduction in any medium, provided the oractivation, the members of the family bind to each other,
forming homodimers or heterodimers [3]. It has been
shown that EGFR is involved in signaling pathways regu-
lating cellular growth, cell cycling, and differentiation
[4]. EGFR is overexpressed in various solid tumors in-
cluding breast, colorectal, ovarian and non-small-cell
lung cancer, and excessive EGFR signaling is associated
with the development of a wide variety of benign and
metastatic tumors [5]. Furthermore, it is reported that
when EGFR is overexpressed, it activates the signaling
transduction system, and therefore cancer cells grow
more aggressively, and with the invasiveness increasing,
the transition occur more easily, affecting negative ef-
fects to the survival rate [6]. Therefore knowledge of theThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The effects of the compounds on cell viability.
3,4-dihydroxyphenyl acetic acid and (+)-epoxydon are isolated
from Aspergillus sp. derived from marine brown alga Ishige
okamurae and Phoma herbarum isolated from marine red alga
Hypnea saidana, respectively.
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(EGF) would assist in searching for targets in cancer
therapy [7].
Over the past several decades, many studies on EGFR-
targeted therapy in cancer have been performed and numer-
ous targets for anticancer agents have emerged. Especially,
monoclonal antibodies (Cetuximab) and tyrosine kinase in-
hibitors (Gefitinib and Erlotinib) have been developed to in-
hibit receptor activation [8,9]. Currently, people prefer
natural products from the ocean or soil rather than chemical
compounds made in a laboratory. In recent years, sea-
weed extracts have been found to have anti-tumor ac-
tivities [10], and many researchers have identified
algae extracts such as fucoidan and carrageenan
which demonstrate anti-tumor effects. The results in-
dicate that the extracts from a wide variety of marine
algae could suppress tumor activities and restrain the
ability of tumors to grow [11,12]. For this reason,
many types of algae extracts have been studied and
possible reasons that the extracts inhibit a variety of
cancers have been elucidated in the field of cell sig-
naling pathways involving apoptosis, death receptor,
and cell cycling [13,14].
Marine fungi were reported having a rich profile of
biologically active metabolites [15]. The ecological pres-
sures of a unique marine environment may drive the
production of new secondary metabolites by microor-
ganisms. As an example, salinosporamide A was isolated
from Salinispora tropica, and was found to cause significant
proteasome inhibition in clinical trials [16]. Chaetomugilins
have been isolated from a strain of Chaetomium globosum
originally isolated from the marine fish Mugil cephalus,
and exhibited significant growth inhibition against human
cancer cell lines [17].
Although a few studies elicited the bioactivities of
metabolites from marine microorganisms, there is no
report about the marine microorganisms symbiotic
with marine algae. The present study was conducted in
order to elucidate the mechanism of the anti-
tumorigenic effects of algae derived microorganism ex-
tracts, we purified 3,4-dihydroxyphenyl acetic acid
from Aspergillus sp. on the marine brown alga Ishige
okamurae and (+)-epoxydon from Phoma herbarum
on the marine red alga Hypnea saidana, respectively.
HeLa human cervical epithelial cancer cells were used
in the study as highly express EGFR tyrosine kinase on
their surface. We studied the inhibitory effects of the
compounds on EGF induced phosphorylation of EGFR
in HeLa cells. The results of this investigation may
provide new insights into the mechanism of tumor
suppression and the possibility for applications in
tumor prevention and treatment, because control of
the activation of EGFR tyrosine kinase has an import-
ant role in tumorigenesis [9].Results and discussion
Physiochemical data for 3,4-dihydroxyphenyl acetic acid
and (+)-epoxydon from marine algae derived
microorganisms
The molecular weight (M.W.) of 3,4-dihydroxyphenyl
acetic acid is 168 (C8H8O4) (Figure 1).
1H NMR (CDCl3,
400 MHz) δ 3.53 (2H, s, H2-2), 6.64 (1H, s, H-2΄), 6.47
(1H, d, J = 7.5 Hz, H-5΄), 6.63 (1H, d, J = 7.5 Hz, H-6΄); 13C
NMR (DMSO, 100 MHz) δ 173.1 (s, C-1), 40.2 (t, C-2),
125.6 (s, C-1΄), 115.3 (d, C-2΄), 144.0 (s, C-3΄) 145.0
(s, C-4΄), 116.6 (d, C-5΄), 120.0 (d, C-6΄); LREIMS m/z:
168 [M]+(50), 151[M-OH]+(29), 123[M-COOH]+(100),
107[M-COOH-OH+H]+(42), 94(26), 77(42).
The molecular weight (M.W.) of (+)-epoxydon is 156
(C7H8O4) (Figure 1). [α]D + 71.6° (c 0.3, MeOH); IR
(neat) νmax 3356, 1680, 1400, 1236, 1027, 903, 867 cm
-1;
UV (MeOH) λmax (log ε) 203 (3.72), 237 (3.68) nm; CD
(MeOH) (Δε) 338 (+0.95), 245 (-1.76) nm; 1H NMR (400
MHz, DMSO-d6) δ 6.39 (1H, dddd, J = 2.7, 2.6, 2.2, 2.1
Hz, H-3), 4.70 (1H, ddddd, J = 6.2, 2.8, 2.8, 2.6, 2.1 Hz,
H-4), 5.79 (1H, d, J = 6.2 Hz, 4-OH), 3.40 (1H, d, J = 4.2
Hz, H-5), 3.76 (1H, ddd, J = 4.2, 2.8, 2.7 Hz, H-6), 3.96
(1H, dddd, J = 15.2, 5.5, 2.8, 2.2 Hz, Ha-7), 4.07 (1H,
dddd, J = 15.2, 5.5, 2.6, 2.1 Hz, Hb-7), 5.01 (1H, t, J = 5.5
Hz, 7-OH); 13C NMR (100 MHz, DMSO-d6) δ 193.9
(s, C-1), 133.8 (s, C-2), 141.4 (d, C-3), 63.7 (d, C-4),
52.9 (d, C-5), 54.0 (d, C-6), 57.3 (t, C-7); CIMS m/z (rel.int.)
156 [M]+ (100), 138 [M-H2O]




Inhibition of EGFR tyrosine kinase activities
The inhibitory activity of EGFR tyrosine kinase for two
compounds, 3,4-dihydroxyphenyl acetic acid and
(+)-epoxydon, were examined in vitro using the
AlphaScreen P-Tyr-100 assay system (Figure 2). EGF re-
ceptor tyrosine kinase assays were performed at the same
conditions to compare 3,4-dihydroxyphenyl acetic acid
and (+)-epoxydon. The activity of the soluble EGF re-
ceptor kinase domain derived from the cytoplasmic
Figure 3 The effects of the compounds on cell viability. The
anti-proliferation of HeLa and HEK293 cells were examined using
WST-1® solution after treatment with each compound and EGF. The
HEK293 (A) and HeLa (B) cells were treated with the indicated
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assay. The kinase domain is constitutively active and
retains its substrate specificities, kinetic constants and
autophosphorylation sites without the requirement for
ligand-mediated activation. The assay uses the broad
spectrum substrate poly [Glu:Tyr] (4:1), and is based
on the binding between the phosphorylated polypep-
tide and the anti-phosphotyrosine antibody (P-Tyr-
100) conjugated to acceptor beads. Shows that both
compounds had inhibitory effect on the activity of
EGFR in dose-dependent manner, and the half max-
imal inhibitory concentrations (IC50 values) for 3,4-
dihydroxyphenyl acetic acid and (+)-epoxydon were
2.8 and 0.6 μg/mL respectively.
Inhibitory effects of the compounds on EGF-induced cell
growth
Cell viability assays were performed to examine the ef-
fects of each compound on cell proliferation. The cells
treated with only EGF were defined as a positive control
during experiments, while others were pre-treated with
each compound at various concentrations prior to treat-
ment with EGF. The results of the cell viability assay
showed that two compounds, 3,4-dihydroxyphenyl acetic
acid and (+)-epoxydon, did not inhibit cell growth and
proliferation in HEK293 (Figure 3A). On the contrary,Figure 2 The inhibitory effects of 3,4-dihydroxyphenyl acetic
acid and (+)-epoxydon on EGFR kinase activity. The inhibitory
effects of the compounds were determined by in vitro kinase assay.
The assays were performed followed by the procedures described in
Materials and Methods. Values shown in the graphs are mean ± SDM
and were obtained from three independent experiments.
concentrations (0, 1, 5, 10, 25, 50, 100 and 200 μg/mL) of each
compound for 40 min, and then exposed to EGF (10 ng/mL for 10
min). Values are expressed relative to that of vehicle-treated cells
(DMSO), normalized to 100%. Values shown in the graphs are mean ±
SEM and were obtained from three independent experiments.HeLa cells treated with each compound for 40 min show
that the rates of proliferation in HeLa cells are decreased
and their inhibition effect was strong on higher concen-
tration (Figure 3B). Additionally, the population of HeLa
cells treated with both compounds was reduced during
observation under an optical microscope (Figure 4). In
comparison to the control cells treated with only EGF,
the numbers of cells treated with both compound and
EGF were lower than the control numbers. When the
cells were exposed to each compound for 48 h, most of
cells were dead and floated.
Activation of EGFR tyrosine kinase by EGF as a positive
control
Epidermal growth factor receptor (EGFR) consists of a
ligand-binding region and a kinase domain [18]. When the
receptor is activated by attachment of an EGF-like ligand
on the ligand-binding region, it undergoes a biochemical
change to phosphorylate each of the residues on the kinase
domain [19]. Especially, phosphorylation of Tyr1068
strongly responds to EGF, and then stimulates mitogenic
[Ras/Raf/MEK/extracellular signal-regulated kinase (ERK)]
Figure 4 Morphological changes of HeLa cells by the treatment of compounds. The cells were treated with each compound (50 μg/mL for
24 or 48 h) and EGF (10 ng/mL for 10 min), except for the control cells treated with EGF only.
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pression levels of active EGFR (phospho-EGFR) were stimu-
lated to a greater extent when the cells were treated with
EGF (Figure 5). Non-phosphorylated EGFR reflects the total
amount of receptor on the cell surface. Thus, it is assumed
that the expression level of phosphorylated EGFR depends
on treatment with EGF results in its activation even if the
amount of receptor exists in the cell is still the same.
Down-regulation of the activated EGFR by the
compounds
EGF plays an important role in the regulation of cell
growth, proliferation, and differentiation by binding to itsFigure 5 EGFR (phosphorylation of tyrosine) activation induced
by EGF. Western blot analysis against phosphorylated form of
Tyr1068 and non-phosphorylated form of EGFR was performed to
examine the effects of various concentrations of EGF (0, 10, 50, 100
ng/ml for 10 min) on the activation of EGFR tyrosine kinase in
HeLa cells.receptor EGFR [21] and stimulating the associated protein
tyrosine kinase activity [22]. Epidermal growth factor recep-
tor (HER1) tyrosine kinase is a recognized target for tumor
therapy and anti-cancer drugs have been developed to in-
hibit receptor activation [23]. Researchers have shown that
the receptor was suppressed by tyrosine kinase inhibitors
(Iressa) [24], monoclonal antibodies such as Cetuximab,
and other compounds [23].
When the cells were treated with each compound before
exposure to EGF, the blocking effect was stronger than
when not treated (Figure 6). It is believed that EGF bind-
ing to the receptor was blocked by those compounds.Figure 6 The inhibitory effects of the compounds on EGF-
induced activation of EGFR. Both 3,4-dihydroxyphenyl acetic acid
and (+)-epoxydon inhibited EGF-induced phosphorylation of Tyr1068
in EGFR. HeLa cells were treated with each compound (50 μg/mL
for 40 min), followed by exposure to EGF (10 ng/mL for 10 min),
except for the negative control (untreated).
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cantly decreased the phosphorylation of EGFR, but not the
EGFR total protein level. In addition, the quantitative
changes of the phosphorylated EGFR were assayed by im-
munofluorescence as shown in Figure 7. The specificity of
antibodies to their antigen was used to target fluorescent
dyes to phosphorylated EGFR within a cell, therefore
allowing visualization of the distribution of the receptor
molecule through the sample. As a result, the shapes of
cells were expressed in green fluorescent light because im-
munofluorescence makes use of fluorophores to visualize
the location of the antibodies and EGFR exists over the en-
tire cell surface. The cells with EGF (Figures 7A and 7D)
had more phosphorylated EGFR compared to untreated
cells (Figures 7B and 7E) and the active functions were
interrupted by the 2 compounds (Figures 7C and 7F).
Inhibition of EGFR-mediated mitogenic signaling
One of the most important protein kinase cascades acti-
vated by tumor promoters, such as EGF, is the mitogen-
activated protein kinase (MAPK), induced by the activation
of EGFR. Ras is a small guanine-nucleotide binding pro-
teins (G-proteins) cycle between active (GTP-bound) and
inactive (GDP-bound) forms [25]. Receptor tyrosine ki-
nases and G-protein-coupled receptors activate Ras, which
then stimulates the Raf-MEK-MAPK pathway [26].
Mitogen-activated protein kinases (MAPKs) constitute a
widely conserved family of serine/threonine protein kinasesFigure 7 Immunofluorescence of the expressions of phosphorylated E
Methods and the images were captured at 488 nm. In control cells (panels
and E), EGF induced the expression of active EGFR (white arrows, brightene
treated with both EGF and each compound (panels C and F).involved in many cellular programs such as cell prolifera-
tion, differentiation, motility, and death. The p44/42
MAPK (Erk1/2) signaling pathway can be activated in re-
sponse to a diverse range of extracellular stimuli including
mitogens, growth factors, and cytokines [27,28] and is an
important target in the diagnosis and treatment of cancer
[29]. Upon stimulation, a sequential 3-part protein kinase
cascade is initiated, consisting of a MAP kinase kinase
kinase (MAPKKK or MAP3K), a MAP kinase kinase
(MAPKK or MAP2K), and a MAP kinase (MAPK).
MEK1 and MEK2 activate p44 and p42 through phos-
phorylation of activation loop residues Thr202/Tyr204
and Thr185/Tyr187, respectively. Several downstream
targets of p44/42 have been identified, including
p90RSK [30] and cytochrome c [31]. Cytochrome c is a
well conserved electron-transport protein and is part
of the respiratory chain localized to the mitochondrial
intermembrane space [32]. Upon apoptotic stimula-
tion, cytochrome c is released from mitochondria, and
this event eventually leads to apoptosis [31].
Therefore, we examined the inhibitory effects of the
compounds on the activities of signal molecules in mito-
genic signaling cascade. As shown in Figure 8, western
blot analysis exhibited that the compounds induced in-
hibition of cell growth as demonstrated by low expres-
sion of signal molecules in the mitogenic signaling
cascade and inactivation of p90RSK. Activation of
p90RSK by response to growth factor prevents release ofGFR. Immunofluorescence was performed as follows by Materials and
A and D) and cells treated with EGF (10 ng/mL for 10 min, panels B
d) but the increased expression levels were not decreased in the cells
Figure 8 Inhibition of the activity of signal molecules in
mitogenic signaling cascade. The compounds inhibited EGF-
induced phosphorylation of EGFR and its downstream signal
molecules in mitogenic signaling. HeLa cells were treated with each
compound (50 μg/mL for 40 min) followed by exposure to EGF
(10 ng/mL for 10 min) except for the negative control (untreated).
Proteins from the cells were resolved by 12% SDS-PAGE and
immunoblotted with indicated antibodies. GAPDH was used as an
internal loading control.
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The results suggest that decreased expression levels of
active EGFR and EGF-related downstream molecules
and the possible involvement of p90RSK by treatment
with the compounds may affect the inhibition of cell
proliferation and induction of mitochondria mediated
apoptosis in Hela cells.
Relative inhibitory effect of the compounds to Tyrphostin
AG 1478 on the activities of EGFR and EGF-related
downstream molecules
Tyrphostin AG 1478 (AG 1478) is a tyrosine kinase in-
hibitor and treatment of cells with AG 1478 can block
EGFR activation in vivo [33,34]. AG 1478 has been
mainly used for laboratory research as an EGFR antag-
onist. There is increasing evidence to suggest that AG 1478
has anti-tumor activity and significant anti-proliferativeFigure 9 Relative inhibitory effects of the compounds to Tyrphostin A
different concentrations of each compound or AG 1478 (10 μg/mL) for 40
analysis performed with the indicated antibodies.effects both in vitro and in vivo [35]. Western blot analysis
exhibited that the compound, 3,4-dihydroxyphenyl acetic
acid, could down-regulate the expression of phosphorylated
EGFR, Ras, phosphorylated MEK, and MAPK, which may
be one of the mechanisms by which AG 1478 suppressed
cellular invasion (Figure 9). The inhibitory effect of 3,4-
dihydroxyphenyl acetic acid was similar to or even better
than AG 1478. In the case of (+)-epoxydon, the inhibitory
effect was not as strong as that of AG 1478, but the expres-
sion levels of each molecule were effectively decreased by
the compound.
Conclusion
In this study, we demonstrated that 3,4-dihydroxyphenyl
acetic acid and (+)-epoxydon from marine algae reduced
expression of the mitogenic signaling cascade and EGFR
activation, leading to apoptosis in HeLa cells because
EGFR has been indicated to be an important target in
cancer therapy.
3,4-dihydroxyphenyl acetic acid is a metabolite of the
neurotransmitter dopamine, and can be oxidized by
hydrogen peroxide, leading to the formation of toxic me-
tabolites which destroy dopamine storage vesicles in the
substantia nigra. (+)-epoxydon is a new secondary me-
tabolite from a marine algae derived fungus. In the
present study, we purified 3,4-dihydroxyphenyl acetic
acid and (+)-epoxydon from Aspergillus sp. isolated from
marine brown alga Ishige okamurae and Phoma
herbarum isolated from marine red alga Hypnea saidana
respectively and determined its anti-tumor activity
against HeLa human cervical cancer cells.
We investigated the antiproliferation effect of two
compounds on HeLa cells. Cell viability assay showed
that two compounds, 3,4-dihydroxyphenyl acetic acid
and (+)-epoxydon, inhibited cell growth and prolifera-
tion at 24 h with IC50 at 21.4 μg/mL and 23.8 μg/mL, re-
spectively. The results indicated that two compounds
from marine algae derived microorganisms blockedG 1478 on the activities. HeLa cells were pre-incubated with
min and then stimulated with EGF (10 ng/ml for 10 min). Western blot
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both compounds may bind with EGF and prevent the
binding of EGF to EGFR. Especially, 3,4-dihydroxyphenyl
acetic acid than (+)-epoxydon down-regulated the ex-
pressions of phosphorylated EGFR, Ras, phosphorylated
MEK ,and MAPK to the same degree as AG 1478, which
is also a tyrosine kinase inhibitor. The compounds also
blocked the phosphorylation of Ras, Raf, MEK, MAPK
and p90RSK-induced cell growth and proliferation. In
contrast, the release of cytochrome c, which results in
apoptosis, was increased by the compounds (Figure 10).
In conclusion, this study demonstrated that the com-
pounds effectively inhibited proliferation and invasion of
HeLa cells and suggests that EGFR may be a potential
therapeutic agent for cervical cancer.
Methods
Isolation for 3,4-dihydroxyphenyl acetic acid and
(+)-epoxydon from marine algae derived microorganisms
The compound, 3,4-dihydroxyphenyl acetic acid (DOPAC),
was isolated from the surface fungus of the marine brown
alga Ishige okamurae collected at Uljin, Gyeongbuk prov-
ince and Geomoon Island, JeonNam province in South
Korea. The fungus was then identified as Aspergillus sp. on
the basis of morphological evaluation and 18S rRNA ana-
lysis (SolGent, Daejeon, South Korea) (similarity 99%). The
fungus was cultured (10 L for 4 weeks (static) at 29°C in a
SWS medium consisting of soytone (0.1%), soluble starchFigure 10 Proposed signaling cascades of the compounds on
EGF-induced p44/42 MAPK (Erk1/2) pathways. The compounds
inhibited the activities of signal molecules in MAPK pathways and
increased release of cytochrome c from mitochondria. It may results
in inhibition of cell proliferation and apoptosis in HeLa cells.(1.0%), and seawater (100%). The resulting broth and my-
celia were extracted separately with EtOAc (ethyl acetate)
and CH2Cl2-MeOH (methanol) (1:1) to afford the broth
extract (430 mg) and the mycelium extract (1.1 g), respect-
ively. The broth extract showed a radical (DPPH) scaven-
ging activity with an IC50 value of 1.1 μg/mL, however, the
mycelium extract was inactive. Therefore, broth extracts
were subjected to column chromatography on silica gel
(n-hexane/EtOAc), and then octadesyl silica (ODS) gel
(H2O/MeOH) to provide 5 fractions. Further purification
of fraction-4 containing 3,4-dihydroxyphenyl acetic acid
by recycling HPLC, followed by HPLC (C18 Apollo,
MeOH-H2O = 3:2), yielded 3,4-dihydroxyphenyl acetic
acid (3.3 mg).
The other compound, (+)-epoxydon, was isolated from
the surface fungus of the marine red alga Hypnea saidana
collected in Tongnyeong and Yokjee Island, GyeongNam
province in South Korea, and then identified as Phoma
herbarum on the basis of morphological evaluation and
18S rRNA analysis (SolGent, Daejeon, South Korea) (simi-
larity, 99%). The culture broth and mycelia were sepa-
rated, and the broth (10 L) was extracted with ethyl
acetate to provide a crude extract (640 mg) which was
subjected to silica gel flash chromatography and
eluted with n-hexane/EtOAc (5:1), n-hexane/EtOAc
(1:1), n-hexane/EtOAc (1:5), n-hexane/EtOAc (1:10),
and finally with EtOAc. The collections (30 mL each)
were combined on the basis of their TLC profiles to
yield 5 major fractions. Medium pressure liquid chro-
matography (MPLC) of fraction-3 on ODS by elution
with MeOH yielded crude (+)-epoxydon (9.0 mg).
The isolated crude (+)-epoxydon was further purified
by HPLC (YMC ODS-A, MeOH) utilizing a 30 min
gradient program of 50% to 100% MeOH in H2O to
yield (+)-epoxydon (5.0 mg).
In vitro assay for EGF receptor tyrosine kinase
The substrate (poly [Glu:Tyr] (4:1)) and the AlphaScreen®
P-Tyr-100 assay kit (PerkinElmer Inc., Waltham, MA,
USA) composed of Donor-streptavidin and Acceptor-
P-Tyr-100 beads were used for the EGF receptor tyrosine
kinase assay. EGFR enzyme purified from human carcin-
oma A431 cells was purchased from Sigma-Aldrich. The
kinase reactions were performed in a mixture of EGFR en-
zyme, ATP, and biotinylated poly [Glu:Tyr] (4:1) in a kin-
ase reaction buffer (50 mM Tris (pH 7.5), 5 mM
MgCl2, 5 mM MnCl2, 2 mM DTT, and 0.01% Tween-20).
The mixture was incubated for 1 h at room temperature
(RT) and then quenched by addition of detection buffer
containing EDTA, Donor-Streptavidin, and Acceptor-
P-tyr-100 beads. After further incubation for 1 h at
RT, the intrinsic kinetic activities were detected as an
AlphaScreen® signal using a Fusion-Alpha microplate
analyzer (PerkinElmer Inc.).
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Human cervical cancer HeLa cells and human embryonic
kidney HEK293 (American Type Culture Collection,
Manassas, VA, USA) cells were grown in Dulbecco's
Modified Eagle's Medium (DMEM) with high-glucose
(HyClone Laboratories, Logan, UT, USA), supplemented
with 10% heat-inactivated fetal bovine serum (HyClone
Laboratories) and penicillin-streptomycin (100 μg/mL
penicillin, and 100 units/mL streptomycin) (PAA Labora-
tories GmbH, PA, Austria) at 37°C with 5% CO2. Human
epidermal growth factor (Sigma-Aldrich, St Louis, MO,
USA) was dissolved in media and treated at a final
concentration of 10 ng/mL. Each compound was
reconstituted with DMSO to 10 mg/mL and added to the
culture media to the final concentration specified in the
test. The same concentration of DMSO was added to the
control dishes. HeLa cells were treated with 50 μg/mL of
each compound for 40 min and then treated with 10 ng/mL
of EGF for 10 min, except for control cells.
Cell viability assay
To estimate the effects of the compounds on cell via-
bility, HeLa and HEK293 cells were seeded (1 × 104
cells/mL) in 96-well plates in 100 μL of DMEM-10%
FBS and cultured for 24 h at 37°C in a 5% CO2 incuba-
tor. After incubation, the HeLa and HEK293 cells were
treated with two compounds (0, 1, 5, 10, 25, 50, 100
and 200 μg/mL) for 40 min, and then exposed to EGF
(10 ng/mL) for 10 min. After treatment, 10 μL of EZ-
Cytox Cell Viability Assay solution WST-1® (Daeil Lab
Service, Jong-No, Korea) was added to each well, and
the cells were then incubated for 3 h at 37°C in a 5% CO2.
Absorbance was measured at 460 nm with an ELISA
reader (Molecular Devices, Sunnyvale, CA, USA).
Protein extraction and western blotting
HeLa cells were cultured with each compound for 40
min and then treated with 100 ng/mL of EGF for 10
min. The cells were then washed twice with cold-PBS,
harvested and lysed with lysis buffer [50 mM Tris-Cl
(pH 7.5), 150 mM NaCl, 1 mM DTT, 0.5% NP-40, 1%
Triton X-100, 1% deoxycholate, 0.1% SDS containing pro-
teinase inhibitors (PMSF, EDTA, Aprotinin, Leupeptin,
Prostatin A, Intron Biotechnology, Gyeonggi, Korea)]. The
lysates were shaken on ice 6 times every 5 min and
centrifuged at 14,000 rpm for 20 min at 4°C. Using bovine
serum albumin (BSA) as a standard, the Protein Quantifi-
cation Kit (CBB solution®) (Dojindo Molecular Technolo-
gies, Rockville, MD, USA) was used for determining the
concentration of whole cell lysates. Each protein was re-
solved by 12% sodium dodecyl sulfate-polyacrylamide gel
(SDS-PAGE) and then transferred onto nitrocellulose
membranes (PALL Life Sciences, Pensacola, MI, USA).
The membranes were blocked with phosphate bufferedsaline-Tween-20 (PBST: 135 mM sodium chloride, 2.7 mM
potassium chloride, 4.3 mM sodium phosphate, 1.4 mM po-
tassium dihydrogen phosphate, 0.5% Tween-20) containing
5% skim milk for 2 h at RT and hybridized with the appro-
priate primary antibody (anti-EGFR (pY1068), anti-EGFR,
anti-Ras, anti-c-Raf (pS338), anti-MEK 1/2 (pS217/221),
anti-MAPK p44/42 (pT202/204), anti-p90RSK (pS380),
anti-cytochrome c, anti-GAPDH (Cell Signaling Technology
Inc., Danvers, MA, USA)) for overnight at 4°C. Protein
bands were visualized by enhanced chemiluminescent (ECL)
detection solution (Pierce, Rockford, IL, USA) after
hybridization for 1 h with the horseradish peroxidase
(HRP)-conjugated secondary antibody from rabbit or mouse
(Cell Signaling Technology Inc.).
Immunofluorescence of the phosphorylated EGFR
HeLa cells were incubated on cover glass-bottom dishes
(SPL Lifesciences, Gyeonggi, Korea) in DMEM with
high-glucose containing FBS (10%) and penicillin-
streptomycin. The cells were fixed with 4% formalde-
hyde (Junsei Chemical Ltd., Japan) for 15 min at RT and
then blocked for 1 h in 5% normal serum based on the
host primary antibody. After removing the blocking buf-
fer, cells were incubated with 0.1 μg/mL of anti-EGFR
(pY1068) overnight at 4°C and then washed 3 times in
cold PBS followed by incubation for 1 h with 0.1 μg/mL
of anti-rabbit IgG (H + L), and F(ab') fragment (Alexa
Fluor 488 conjugate) (Cell Signaling Technology Inc.).
After washing, the stained cells were mounted with Prolong
Gold Antifade Reagent (Invitrogen, Eugene, OR, USA) and
then observed under a Nikon ECLIPS 50i microscope
equipped with a charged-coupled device (CDD) camera
(Nikon, Tokyo, Japan). Images were captured and
processed with High-Content Analysis Software (Cam-
bridge Healthtech Institute, Needham, MA, USA).
Statistical analysis
The statistical significance of the differences between the
values of compound-treated and non-treated groups was
determined by GraphPad Prism 5.0. The results are
expressed as mean values ± standard deviations of the
mean (SDM). Every untreated control group and treated
group was measured in differences by t-tests. (p < 0.05
was considered significant). The experiments were
performed in triplicates and at least three times each. In
case of no error bar in the graph, the variation of values
is infinitesimal and thus, the bars are hidden behind.
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